JP2013514093A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514093A5
JP2013514093A5 JP2012543413A JP2012543413A JP2013514093A5 JP 2013514093 A5 JP2013514093 A5 JP 2013514093A5 JP 2012543413 A JP2012543413 A JP 2012543413A JP 2012543413 A JP2012543413 A JP 2012543413A JP 2013514093 A5 JP2013514093 A5 JP 2013514093A5
Authority
JP
Japan
Prior art keywords
sponge
enhances
adhesion
tissue
crosslinkable component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012543413A
Other languages
English (en)
Other versions
JP2013514093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AT2010/000486 external-priority patent/WO2011079336A1/en
Publication of JP2013514093A publication Critical patent/JP2013514093A/ja
Publication of JP2013514093A5 publication Critical patent/JP2013514093A5/ja
Pending legal-status Critical Current

Links

Description

本明細書に開示するようなスポンジと薬学的活性物質とを含む創傷被覆材(wound
coverage)を調製するためのキットも提供する。このキット及びその成分は、特に、傷害の処置のための医用スポンジの製造用である。
本発明は、例えば以下の項目を提供する。
(項目1)
止血性複合スポンジであって、該スポンジは、
生体材料のマトリックスの多孔質スポンジと、
該スポンジの少なくとも1つの表面と安定に結合する、適用組織に対する該スポンジの付着性を増強する材料と
を含み、ここで、該材料がヒドロゲル形成成分を本質的に含まない、止血性複合スポンジ。
(項目2)
前記生体材料が、コラーゲン、ゼラチン、フィブリン、多糖、例えばキトサン、及びその誘導体からなる群から選択される、項目1に記載のスポンジ。
(項目3)
前記適用組織に対する前記スポンジの付着性を増強する前記材料が、第1の架橋可能成分と、反応可能な条件下で該第1の架橋可能成分と架橋する第2の架橋可能成分とを含む、2種類のプレポリマーの混合物、又は前もって形成されたポリマーである、項目1又は2に記載のスポンジ。
(項目4)
前記第1及び/又は第2の架橋可能成分が、ポリエチレングリコールの誘導体を含む、項目1から3のいずれか一項に記載のスポンジ。
(項目5)
前記適用組織に対する前記スポンジの付着性を増強する前記材料が、該スポンジの少なくとも1つの表面に連続又は不連続な層を形成する、項目1から4のいずれか一項に記載のスポンジ。
(項目6)
全厚が約1mmから約2.5mmである、項目1から5のいずれか一項に記載のスポンジ。
(項目7)
低侵襲手術において、例えば腹腔鏡検査適用に使用するための、項目1から6のいずれか一項に記載のスポンジ。
(項目8)
前記適用組織に対する前記スポンジの付着性を増強する前記材料が、生体材料1cm 当たり5から500mg、好ましくは1cm 当たり5から100mgの濃度で存在する、項目1から7のいずれか一項に記載のスポンジ。
(項目9)
止血性複合スポンジを製造する方法であって、
a)生体材料のマトリックスの多孔質スポンジを用意する工程、
b)適用組織に対する該スポンジの付着性を増強する材料を懸濁物、溶液又は粉体の形態で用意する工程であって、ここで該材料はヒドロゲル形成成分を本質的に含まない工程、
c)止血性複合スポンジが得られるように、b)の該材料が該スポンジの少なくとも1つの表面と安定に結合するように、a)とb)を接触させる工程、必要に応じて
d)工程c)で得られた該複合スポンジを乾燥させる工程、必要に応じて
e)工程c)又はd)で得られた該複合スポンジを滅菌する工程
を含む、方法。
(項目10)
項目1から7のいずれか一項に記載の止血性複合スポンジを施す工程を含む、創傷、出血、損傷組織及び/又は出血組織を処置する方法。

Claims (10)

  1. 止血性複合スポンジであって、該スポンジは、
    生体材料のマトリックスの多孔質スポンジと、
    該スポンジの少なくとも1つの表面と安定に結合する、適用組織に対する該スポンジの付着性を増強する材料と
    を含み、ここで、該材料がヒドロゲル形成成分を本質的に含まない、止血性複合スポンジ。
  2. 前記生体材料が、コラーゲン、ゼラチン、フィブリン、多糖、例えばキトサン、及びその誘導体からなる群から選択される、請求項1に記載のスポンジ。
  3. 前記適用組織に対する前記スポンジの付着性を増強する前記材料が、第1の架橋可能成分と、反応可能な条件下で該第1の架橋可能成分と架橋する第2の架橋可能成分とを含む、2種類のプレポリマーの混合物、又は前もって形成されたポリマーである、請求項1又は2に記載のスポンジ。
  4. 前記第1及び/又は第2の架橋可能成分が、ポリエチレングリコールの誘導体を含む、請求項1から3のいずれか一項に記載のスポンジ。
  5. 前記適用組織に対する前記スポンジの付着性を増強する前記材料が、該スポンジの少なくとも1つの表面に連続又は不連続な層を形成する、請求項1から4のいずれか一項に記載のスポンジ。
  6. 全厚が約1mmから約2.5mmである、請求項1から5のいずれか一項に記載のスポンジ。
  7. 低侵襲手術において、例えば腹腔鏡検査適用に使用するための組成物であって、請求項1から6のいずれか一項に記載のスポンジを含む、組成物
  8. 前記適用組織に対する前記スポンジの付着性を増強する前記材料が、生体材料1cm当たり5から500mg、好ましくは1cm当たり5から100mgの濃度で存在する、請求項1からのいずれか一項に記載のスポンジまたは請求項7に記載の組成物
  9. 止血性複合スポンジを製造する方法であって、
    a)生体材料のマトリックスの多孔質スポンジを用意する工程、
    b)適用組織に対する該スポンジの付着性を増強する材料を懸濁物、溶液又は粉体の形態で用意する工程であって、ここで該材料はヒドロゲル形成成分を本質的に含まない工程、
    c)止血性複合スポンジが得られるように、b)の該材料が該スポンジの少なくとも1つの表面と安定に結合するように、a)とb)を接触させる工程、必要に応じて
    d)工程c)で得られた該複合スポンジを乾燥させる工程、必要に応じて
    e)工程c)又はd)で得られた該複合スポンジを滅菌する工程
    を含む、方法。
  10. 請求項1から7のいずれか一項に記載の止血性複合スポンジを含む、創傷、出血、損傷組織及び/又は出血組織を処置するための組成物
JP2012543413A 2009-12-16 2010-12-16 止血スポンジ Pending JP2013514093A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28708809P 2009-12-16 2009-12-16
US61/287,088 2009-12-16
PCT/AT2010/000486 WO2011079336A1 (en) 2009-12-16 2010-12-16 Hemostatic sponge

Publications (2)

Publication Number Publication Date
JP2013514093A JP2013514093A (ja) 2013-04-25
JP2013514093A5 true JP2013514093A5 (ja) 2013-12-19

Family

ID=43877202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543413A Pending JP2013514093A (ja) 2009-12-16 2010-12-16 止血スポンジ

Country Status (11)

Country Link
US (6) US8771258B2 (ja)
EP (1) EP2512535A1 (ja)
JP (1) JP2013514093A (ja)
KR (1) KR101811070B1 (ja)
CN (1) CN102753203A (ja)
AU (1) AU2010339045B2 (ja)
BR (1) BR112012014773A2 (ja)
CA (1) CA2784432C (ja)
CO (1) CO6541650A2 (ja)
MX (1) MX2012007056A (ja)
WO (1) WO2011079336A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
PL2442835T3 (pl) * 2009-06-16 2015-07-31 Baxter Int Gąbka hemostatyczna
EP2498820B1 (en) 2009-11-13 2019-01-09 University of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
WO2011079336A1 (en) 2009-12-16 2011-07-07 Baxter International Inc. Hemostatic sponge
EP2515957B1 (en) 2009-12-22 2015-07-29 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
CN103118713B (zh) 2010-08-05 2016-06-01 生命连结有限公司 干组合物伤口敷料及粘合剂
US9616088B2 (en) 2013-03-13 2017-04-11 Gel-E, Inc. Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
CN104147251A (zh) * 2014-08-19 2014-11-19 高祥根 消肿止痛的复方明胶海绵及制备方法
US10660945B2 (en) 2015-08-07 2020-05-26 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US10751444B2 (en) 2015-08-07 2020-08-25 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
AU2016313773B2 (en) * 2015-09-01 2020-11-26 Baxter International Inc. Hemostatic material
NL2016527B1 (en) 2016-03-31 2017-11-02 Polyganics Ip B V Tissue-adhesive biomedical materials.
NL2016524B1 (en) 2016-03-31 2017-10-17 Polyganics Ip B V Tissue-adhesive material
AU2018230378A1 (en) * 2017-03-09 2019-10-31 Baxter Healthcare Sa Solvent deposition system and methods
US10953130B2 (en) 2017-08-31 2021-03-23 Victor Matthew Phillips Solid hemostatic composition and methods of making the same
NL2019652B1 (en) 2017-09-29 2019-04-08 Polyganics Ip B V Tissue-adhesive sealant device
CN108478849B (zh) * 2018-02-07 2021-04-16 广州迈普再生医学科技股份有限公司 一种可吸收可黏附止血海绵及其制备方法
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
NL2023358B1 (en) 2019-06-21 2021-02-01 Polyganics Ip B V Dopamine-functionalized polymers
US20210213157A1 (en) * 2020-01-09 2021-07-15 Ethicon, Inc. Flexible Gelatin Sealant Dressing with Reactive Components
KR102164819B1 (ko) * 2020-03-02 2020-10-13 주식회사 이노테라피 지혈용 기구 및 이의 제조방법
KR102457814B1 (ko) * 2020-11-25 2022-10-21 주식회사 애니메디앤헬스케어 지혈패드 및 이의 제조방법
US20220331475A1 (en) * 2021-02-10 2022-10-20 Ethicon, Inc. Two Component Sealing Systems Including Synthetic Matrices and Biosynthetic Adhesives
AU2022413984A1 (en) * 2021-12-17 2024-07-04 Medskin Solutions Dr. Suwelack Ag Composition comprising a biomaterial-based porous material coated with a powder
CN116785493B (zh) * 2023-07-13 2024-04-05 南京普立蒙医疗科技有限公司 一种中空复合型双层鼻腔止血海绵、制备方法及其应用

Family Cites Families (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507244A (en) * 1947-04-14 1950-05-09 Upjohn Co Surgical gelatin dusting powder and process for preparing same
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
SE420565B (sv) 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
US4013078A (en) * 1974-11-25 1977-03-22 Feild James Rodney Intervertebral protector means
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
US4179400A (en) 1978-05-09 1979-12-18 W. R. Grace & Co. Process for preparing catalytic solutions of sulfonium salts
AT359653B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359652B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3036033A1 (de) 1980-09-24 1982-05-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung
US4300494A (en) 1979-09-26 1981-11-17 Shell Oil Company Thermal insulated intake ports
US4292972A (en) 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
US4482386A (en) 1982-03-26 1984-11-13 Warner-Lambert Company Method of conditioning a water swellable hydrocolloid
US4543332A (en) * 1982-03-29 1985-09-24 Miles Laboratories, Inc. Method for the preparation of spherical microorganism cell aggregates
US4540410A (en) * 1982-11-16 1985-09-10 Serono Pharmaceutical Partners Lyophilized compositions, preparation and use thereof
JPS59113889A (ja) 1982-12-17 1984-06-30 Sumitomo Chem Co Ltd 固定化酵素もしくは固定化微生物菌体の製造方法
JPS59113889U (ja) 1983-01-24 1984-08-01 西部電機工業株式会社 カウンタ式エンコ−ダ
DE3466702D1 (en) 1983-07-14 1987-11-12 Hitachi Chemical Co Ltd Gelatin spherical gels and production thereof
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4515637A (en) * 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
SE456346B (sv) 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
GB8422950D0 (en) * 1984-09-11 1984-10-17 Warne K J Hydrogel
JPS61122222A (ja) * 1984-11-19 1986-06-10 Koken:Kk コラ−ゲン又はゼラチンとプロタミンとよりなる止血剤
US5165938A (en) 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5178883A (en) * 1984-11-29 1993-01-12 Regents Of The University Of Minnesota Method for promoting hair growth
US4600533A (en) 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US5007916A (en) * 1985-08-22 1991-04-16 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
IL78826A (en) * 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4803075A (en) 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5140016A (en) * 1988-05-31 1992-08-18 University Of Florida Method and composition for preventing surgical adhesions using a dilute solution of polymer
US5350573A (en) * 1988-05-31 1994-09-27 University Of Florida Research Foundation, Inc. Method and composition for preventing surgical adhesions
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5041292A (en) * 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5135751A (en) * 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5614587A (en) * 1988-11-21 1997-03-25 Collagen Corporation Collagen-based bioadhesive compositions
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
DE3903672C1 (ja) * 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
DK223389D0 (da) 1989-05-05 1989-05-05 Ferrosan As Saarsvamp
DE69004098T2 (de) 1989-08-10 1994-08-04 Gore & Ass Medizinisches spendesystem für gewebeklebstoffkomponenten.
US5196185A (en) 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
FR2652573B1 (fr) 1989-10-03 1991-12-13 Atochem Procede de fabrication du 1,1,1-chlorodifluoroethane.
US5061274A (en) 1989-12-04 1991-10-29 Kensey Nash Corporation Plug device for sealing openings and method of use
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
US5306501A (en) * 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
US5634943A (en) 1990-07-12 1997-06-03 University Of Miami Injectable polyethylene oxide gel implant and method for production
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5209776A (en) * 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5192300A (en) * 1990-10-01 1993-03-09 Quinton Instrument Company Insertion assembly and method of inserting a vessel plug into the body of a patient
US5108421A (en) * 1990-10-01 1992-04-28 Quinton Instrument Company Insertion assembly and method of inserting a vessel plug into the body of a patient
ZA918168B (en) * 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
US5129882A (en) * 1990-12-27 1992-07-14 Novoste Corporation Wound clotting device and method of using same
US5690675A (en) 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JPH06500802A (ja) * 1991-06-14 1994-01-27 アムジエン・インコーポレーテツド コラーゲンフィルムによるタンパクのドラッグ・デリバリー
NL9101051A (nl) 1991-06-18 1993-01-18 Ashridge Ag Sluitinrichting voor een bloedvat of dergelijke.
AT398079B (de) 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AU666712B2 (en) 1992-02-28 1996-02-22 Cohesion Technologies, Inc. Injectable ceramic compositions and methods for their preparation and use
EP0632820B1 (en) 1992-02-28 2000-05-17 Collagen Corporation High concentration homogenized collagen compositions
US5468505A (en) 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5204382A (en) 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5384333A (en) * 1992-03-17 1995-01-24 University Of Miami Biodegradable injectable drug delivery polymer
CA2134071C (en) * 1992-04-23 1999-04-27 Sew Wah Tay Apparatus and method for sealing vascular punctures
IL105529A0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
JPH05308969A (ja) 1992-05-13 1993-11-22 Japan Vilene Co Ltd 酵素保持体及びその製造方法
WO1993024476A1 (en) * 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
US5413571A (en) * 1992-07-16 1995-05-09 Sherwood Medical Company Device for sealing hemostatic incisions
US5428022A (en) * 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
DE4227681C2 (de) 1992-08-21 1995-05-18 Becker & Co Naturinwerk Wundabdeckungsmaterial auf der Basis von Kollagenfasern und Verfahren zu seiner Herstellung
ATE206602T1 (de) * 1992-11-12 2001-10-15 Neville Alleyne Einrichtung zum schutz des herzens
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
JPH08131B2 (ja) 1993-03-05 1996-01-10 新田ゼラチン株式会社 止血用パッド
WO1994027630A1 (fr) 1993-05-31 1994-12-08 Kaken Pharmaceutical Co., Ltd. Preparation de gel a base de gelatine reticulee contenant un facteur de croissance de fibroblaste de base
JPH0790241A (ja) 1993-09-22 1995-04-04 Menicon Co Ltd 眼用レンズ材料用仮接着剤
DE69433939T2 (de) 1993-11-03 2005-08-11 Clarion Pharmaceuticals, Inc., Madison Hämostatisches pflaster
FR2715309B1 (fr) * 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
US5674275A (en) 1994-04-06 1997-10-07 Graphic Controls Corporation Polyacrylate and polymethacrylate ester based hydrogel adhesives
US5531759A (en) * 1994-04-29 1996-07-02 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
GB9415739D0 (en) 1994-07-30 1994-09-21 Scimat Ltd Gel wound dressing
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5653699A (en) * 1994-09-13 1997-08-05 Polymedica Industries, Inc. Spyrosorbent wound dressings for exudate management
AU1287895A (en) 1994-10-03 1996-04-26 Otogen Corporation Differentially biodegradable biomedical implants
FR2726571B1 (fr) 1994-11-03 1997-08-08 Izoret Georges Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique
US5698213A (en) 1995-03-06 1997-12-16 Ethicon, Inc. Hydrogels of absorbable polyoxaesters
US5580923A (en) 1995-03-14 1996-12-03 Collagen Corporation Anti-adhesion films and compositions for medical use
US5677284A (en) 1995-06-06 1997-10-14 Regen Biologics, Inc. Charged collagen particle-based delivery matrix
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
DE69636289T2 (de) 1995-12-18 2007-05-10 Angiodevice International Gmbh Vernetzten polymerisatmassen und verfahren für ihre verwendung
US5748318A (en) * 1996-01-23 1998-05-05 Brown University Research Foundation Optical stress generator and detector
JP2000510357A (ja) * 1996-04-04 2000-08-15 イムノ・アクチエンゲゼルシャフト コラーゲンを基にした止血スポンジ
US5902832A (en) * 1996-08-20 1999-05-11 Menlo Care, Inc. Method of synthesizing swollen hydrogel for sphincter augmentation
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) * 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6706690B2 (en) * 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7320962B2 (en) * 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6117444A (en) 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
US6458386B1 (en) 1997-06-03 2002-10-01 Innogenetics N.V. Medicaments based on polymers composed of methacrylamide-modified gelatin
US5908054A (en) * 1997-06-16 1999-06-01 Fusion Medical Technologies, Inc. Fluid dispersion and delivery assembly and method
WO1999013902A1 (en) 1997-09-16 1999-03-25 Integra Lifesciences Corporation Product for promoting dural or meningeal tissue growth comprising collagen
US5997895A (en) 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6179872B1 (en) * 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
FR2783429B1 (fr) * 1998-09-18 2002-04-12 Imedex Biomateriaux Materiau collagenique bicomposite,son procede d'obtention et ses applications therapeutiques
US6110484A (en) * 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
US6328229B1 (en) 1998-12-18 2001-12-11 Cohesion Technologies, Inc. Low volume mixing spray head for mixing and dispensing of two reactive fluid components
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
JP2003508564A (ja) * 1999-08-27 2003-03-04 コヒージョン テクノロジーズ, インコーポレイテッド 高強度の医療用シーラントとして使用するための相互侵入ポリマー網目構造を形成する組成物
US6221109B1 (en) 1999-09-15 2001-04-24 Ed. Geistlich Söhne AG fur Chemische Industrie Method of protecting spinal area
US6312474B1 (en) 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials
JP2003535165A (ja) * 2000-05-30 2003-11-25 ビリディス バイオテック インコーポレイテッド ポリユビキチン系ヒドロゲルとその用途
AU2001291092B2 (en) 2000-09-18 2007-08-23 Organogenesis Inc. Bioengineered flat sheet graft prosthesis and its use
CZ20032199A3 (cs) 2001-01-25 2003-12-17 Nycomed Pharma As Suspenze obsahující fibrinogen, trombin a alkohol, způsob přípravy této suspenze, způsob pokrytí nosiče touto suspenzí, způsob vysušení pokrytí nosiče a pokrytá kolagenová houba
AU2002300450B2 (en) 2001-08-10 2007-04-05 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen Carrier of Therapeutic Genetic Material, and Method
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
WO2004108179A1 (en) 2003-06-05 2004-12-16 Baxter International Inc. Compositions for repairing and regenerating human dura mater
JP2007516740A (ja) * 2003-11-10 2007-06-28 アンジオテック インターナショナル アーゲー 医療移植片(implants)および瘢痕化抑制剤
US20080091277A1 (en) * 2004-08-13 2008-04-17 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
US8414907B2 (en) * 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US8246990B2 (en) 2005-05-04 2012-08-21 Suprapolix B.V. Hydrogen bonded hydrogels
JP2007001963A (ja) * 2005-06-21 2007-01-11 Koji Kibune 吸水性の高いキトサンスポンジの製造方法
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair
JP5160102B2 (ja) * 2006-02-14 2013-03-13 甲陽ケミカル株式会社 非晶質の部分脱アセチル化キチン塩のスポンジ状止血材及びその製造方法
CN101454030B (zh) * 2006-05-31 2013-06-26 巴克斯特国际公司 用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
EP2214734B1 (en) * 2007-10-30 2017-12-13 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
EP2210917A1 (en) 2007-11-01 2010-07-28 Osaka City University -1,3-glucan-derived polyaldehyde/polyamine hydrogel
US20100100123A1 (en) 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
PL2442835T3 (pl) 2009-06-16 2015-07-31 Baxter Int Gąbka hemostatyczna
WO2011079336A1 (en) 2009-12-16 2011-07-07 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف

Similar Documents

Publication Publication Date Title
JP2013514093A5 (ja)
Montazerian et al. Engineered hemostatic biomaterials for sealing wounds
Hickman et al. Biomaterials and advanced technologies for hemostatic management of bleeding
Li et al. Bioactive materials promote wound healing through modulation of cell behaviors
Muthiah Pillai et al. Injectable nano whitlockite incorporated chitosan hydrogel for effective hemostasis
Rathi et al. Protein‐based bioadhesives and bioglues
Peng et al. Novel wound sealants: Biomaterials and applications
KR102244014B1 (ko) 피브리노겐­기반 조직 접착 패치
Hu et al. Antibacterial hemostatic dressings with nanoporous bioglass containing silver
Tan et al. Tannic acid/CaII anchored on the surface of chitin nanofiber sponge by layer-by-layer deposition: Integrating effective antibacterial and hemostatic performance
JP6224069B2 (ja) 組織適合特性を有する抗菌剤の組成物および使用
US20140303261A1 (en) Adhesive Composition
Pinkas et al. Structuring of composite hydrogel bioadhesives and its effect on properties and bonding mechanism
WO2008019126A3 (en) Process for production of solid wound dressing
WO2003009810B1 (en) Silver alginate foam compositions
JP2016530035A (ja) 生体接着に使用するためのナノ粒子
Che et al. Surface-adaptive and on-demand antibacterial sponge for synergistic rapid hemostasis and wound disinfection
JP2010510818A5 (ja)
JP2013532139A5 (ja)
JP2013523296A5 (ja)
EP2701908A1 (en) Coating compositions, methods and coated devices
US20110218472A1 (en) Non drug based wound dressing polymer film and a method of producing the same
Jiang et al. Hemostatic biomaterials to halt non-compressible hemorrhage
Peng Biomaterials for hemorrhage control
Pant et al. Antibacterial and cellular response toward a gasotransmitter-based hybrid wound dressing